2024 Preceptor Appreciation Day

September 19, 2024 | 8:40-9:40 a.m.

This presentation will provide preceptors with a summary of the roles and responsibilities of experiential faculty and staff to enhance communication among students, preceptors and the Office of Experiential Education.

Best practices for disability-related accommodations will also be discussed.

At the completion of this activity, the participant should be able to:

• Describe the roles and responsibilities of the MCPHS Experiential team-Boston/Worcester/Manchester, including faculty and staff
• Identify how preceptors can communicate with the Office of Experiential Education
• Discuss disability-related accommodations in the experiential setting

Presenters

Kara Bonaceto, PharmD, BCPS, RPh, is Director of the Office of Experiential Education for the MCPHS Worcester/Manchester program. Kara received her PharmD from the University of Rhode Island. She has been Board Certified in Pharmacotherapy since 2007. Kara joined MCPHS as an Experiential faculty Coordinator in 2010. Prior to joining MCPHS, Kara was a hospital pharmacist and precepted students on an Internal Medicine rotation. Kara is a member of the American Association of College of Pharmacy (AACP) and Massachusetts Pharmacists Association (MPhA).

Nicole Carace, PharmD, MHA, RPh, is a graduate of MCPHS and has been a faculty coordinator in the Office of Experiential Education since 2011. Prior to that, Nicole was a clinical pharmacist and director of pharmacy services in a hospital setting. Nicole also has her Masters in Healthcare Administration from New England College and is a member of AACP.

Andrew Szumita, PharmD, BS, RPh, is the Director of the Office of Experiential Education for the MCPHS Boston campus. Andrew received his PharmD from the University of Rhode Island. Andrew joined MCPHS as an Experiential Faculty Coordinator in 2012. Prior to joining MCPHS, Andrew worked primarily in long-term care, specializing in sterile compounding and management. He precepted students on IPPE and APPE Institutional rotations. Andrew is a member of the American Association of Colleges of Pharmacy (AACP).

Activity Number: 0026-0000-24-020-L99-P | Knowledge-based
Topic Designator: Additional Topic Areas
Contact Hours: 1.0

September 19, 2024 | 9:50-10:50 a.m.

The purpose of this presentation is to explore learning through the social construction of new knowledge by pharmacy students engaged in experiential learning in a post-pandemic world that is now heavily reliant on remote learning.

Academic leaders and practitioners are responding to calls for the redesign of experiential education that will better prepare future pharmacists for practice. This has broad implications for educational programs and health care delivery. Situated learning theory will help frame the discussion around context, while focusing on our understanding of how students construct knowledge in a social setting.

The presentation will discuss the five factors that provide insights into the students' knowledge-construction process. They are (1) personal identity, (2) participation, (3) practitioners, (4) context, and (5) content. This discussion can guide preceptors in designing more effective rotations. For the profession of pharmacy, a well-developed experiential program will enable new pharmacists to meet the many challenges of providing high-quality patient-centered care and of navigating a complex health care delivery system.

At the completion of this activity, the participant should be able to:

• Identify the components of context-based, situational learning, and its application during rotation
• Integrate personal and professional real-world experiences into clinical teaching to enhance contextual learning
• Share examples of storytelling with students to increase their ability to better provide patient care
• Involve students on rotation with that community of practice to help increase their knowledge, skills, and affect
• Develop a teaching approach that considers the socio-cultural aspects of the learner

Presenter

Paul DiFrancesco, EdD, BS, MPA, RPh has practiced as a pharmacist for over 40 years, working as a pharmacy director, then in academics as a Dean and member of faculty. He received his PharmD from Northeastern University, Master's in public administration from Suffolk University, and then a doctorate in educational administration from the University of Massachusetts. He currently serves at MCPHS as the Associate Dean of Pharmacy Experiential Education for all three campuses. As a faculty member, his main focus is on student learning, development, and success.

Activity Number: 0026-0000-24-021-L99-P | Knowledge-based
Topic Designator: Additional Topic Areas
Contact Hours: 1.0

September 19, 2024 | 11:05 a.m.-12:05 p.m.

This presentation will provide a discussion on where pharmacy preceptors can find new proposed regulations on both the federal and Massachusetts state level. In addition, the CE will discuss the scope of practice for pharmacists, pharmacy interns and pharmacy technicians. The session will conclude by looking at selected topics in the area of new policies and regulations impacting the practice of pharmacy.

At the completion of this activity, the participant should be able to:

• Identify where a pharmacy preceptor can find a proposed new regulation relating to pharmacy law
• Compare the scope of practice of pharmacists, pharmacy interns and pharmacy technicians in the Commonwealth of Massachusetts
• List at least five pharmacy law related regulations or policies that pharmacy preceptors can review with their interns

Presenter

Frederick Frankhauser, JD, MBA, RPh is a Professor of Pharmaceutical Business and Administrative Sciences at MCPHS University. Fred earned his JD from Western New England University, MBA from Fitchburg State University and his BS in Pharmacy from MCPHS University. He works directly with leaders in the Life Sciences Industry on workforce development Regulatory Affairs and Health Policy matters. Fred has taught courses in Pharmacy Law, Regulatory Affairs, Clinical Research Coordination, Health Care Delivery and Health Policy.

Activity Number: 0026-0000-24-022-L03-P | Knowledge-based
Topic Designator: Law
Contact Hours: 1.0

September 19, 2024 | 1:20-2:20 p.m.

Learning differences are the individual and unique ways in which some people process new information. In this presentation, participants will learn best practices building for a culturally inclusive environment that supports students through cultural awareness and empathy. This in turn enables preceptors to avoid misunderstandings and allows for cross-cultural learning.

At the completion of this activity, the participant should be able to:

• Understand the concept of cultural awareness
• Define cultural competence
• Identify different styles of learning
• Utilize strategies to support college students with learning differences

Presenters

Clara Reynolds is the Chief Inclusion Officer at MCPHS. She is a highly accomplished attorney and DEI professional with two decades of experience. She has significant expertise in Leadership, Human Resources, Diversity Management, Employee Relations, Contracts, Compliance, Criminal Law, Employment and Labor Negotiations.

Madeleine E. López is the Assistant Director of the Office of Inclusion at MCPHS. She has over 15 years of experience as a director, administrator and educator on issues related to diversity and social justice. She is a writer, professional presenter, curriculum designer and trainer on issues of race, ethnicity and social equality.

Activity Number: 0026-0000-24-024-L99-P | Knowledge-based
Topic Designator: Additional Topic Areas
Contact Hours: 1.0

September 19, 2024 | 2:30-3:30 p.m.

This continuing education presentation will review the definition and goals of precision medicine and pharmacogenomics, as well as associated terminology. It will cover the benefits and limitations of pharmacogenomic testing, which is important to set both provider and patient expectations.

The bulk of the presentation will focus on the application of pharmacogenomic test results, including how to interpret them in the context of a prodrug versus an active drug, resources that are available for pharmacogenomics interpretation and dosing recommendations, and how pharmacogenomics can be leveraged in a clinical setting.

At the completion of this activity, the participant should be able to:

• Define precision medicine
• Explain how genetic testing, including pharmacogenomic testing, can benefit patients
• Describe key resources for evidence-based clinical pharmacogenomics information

Presenters

Roseann S. Donnelly, PharmD, FCCP, BCPS, is an Associate Professor of Pharmacy Practice at Massachusetts College of Pharmacy and Health Sciences in Boston. She received her Doctor of Pharmacy degree from MCPHS. Her post-graduate training included a specialty residency in Clinical Pharmacogenetics at St. Jude Children’s Research Hospital in Memphis, Tennessee. Dr. Donnelly is a Board Certified Pharmacotherapy Specialist, and a nationally recognized expert in the field of pharmacogenomics. She is the co-founder and lead clinical pharmacist for the Pharmacogenomics Clinic at Brigham and Women’s Hospital in Boston.

Samantha Frear, PharmD, is an Assistant Professor of Pharmacy Practice at Massachusetts College of Pharmacy and Health Sciences in Boston. She received her Doctor of Pharmacy degree from University of the Sciences – Philadelphia College of Pharmacy in Philadelphia, PA. Her post-graduate training included a specialty residency in Clinical Pharmacogenetics at Sanford Imagenetics in Sioux Falls, South Dakota. Dr. Frear serves as a clinical pharmacist for the Pharmacogenomics Clinic at Brigham and Women’s Hospital in Boston.

Activity Number: 0026-0000-24-023-L01-P | Knowledge-based
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0

• Andrew Szumita, PharmD, BS, RPh, Director, Office of Experiential Education, MCPHS-Boston
• Kara Bonaceto, PharmD, BCPS, RPh, Director, Office of Experiential Education, MCPHS-Worcester/Manchester
• Nicole Carace, PharmD, MHA, RPh, Faculty Coordinator, Office of Experiential Education MCPHS-Worcester/Manchester
• Paul DiFrancesco, EdD, BS, MPA, RPh, Associate Dean of Pharmacy Experiential Education, MCPHS
• Fred Frankhauser, JD, MBA, RPh, Professor of Pharmaceutical Business & Administrative Sciences, Massachusetts College of Pharmacy and Health Sciences
• Clara Reynolds, Chief Inclusion Officer, MCPHS
• Madeleine Lopez, Assistant Director of the Office of Inclusion, MCPHS
• Roseann Donnelly, PharmD, FCCP, BCPS, Associate Professor of Pharmacy Practice, MCPHS-Boston
• Samantha Frear, PharmD, Assistant Professor of Pharmacy Practice, MCPHS-Boston

Crowne Plaza Boston-Woburn
15 Middlesex Canal Park Road
Woburn, MA 01801

Parking is complimentary.

Get directions. 

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants of the 2024 Preceptor Appreciation Day will receive 5 contact hours (0.5 CEU), including one hour of pharmacy law.

In order to receive credit, the participant must be present the entirety of each presentation and complete post-tests, and evaluation forms for each session on mcphsce.org. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Disclosures

Andrew Szumita has no relevant financial relationships with ineligible companies to disclose.

Kara Bonaceto has no relevant financial relationships with ineligible companies to disclose.

Nicole Carace has no relevant financial relationships with ineligible companies to disclose.

Paul DiFrancesco has no relevant financial relationships with ineligible companies to disclose.

Fred Frankhauser has no relevant financial relationships with ineligible companies to disclose.

Clara Reynolds has no relevant financial relationships with ineligible companies to disclose.

Madeleine Lopez has no relevant financial relationships with ineligible companies to disclose.

Roseann Donnelly has no relevant financial relationships with ineligible companies to disclose.

Samantha Frear has no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.